What percentage of pituitary (adenohypophysis) adenomas cause Cushing's syndrome?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 5, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Porcentaje de Adenomas Hipofisiarios que Causan Cushing

Los corticotropinomas (adenomas secretores de ACTH que causan enfermedad de Cushing) representan aproximadamente el 4% de todos los adenomas hipofisiarios en adultos, aunque esta proporción varía significativamente según la edad del paciente. 1

Epidemiología por Grupo de Edad

En Población Pediátrica y Adolescente

  • Los corticotropinomas son el tipo más común de adenoma hipofisario en la infancia temprana, representando el 55% de todos los adenomas hipofisarios en niños de 0-11 años 2
  • En adolescentes de 12-17 años, los corticotropinomas representan aproximadamente el 30% de los adenomas hipofisarios 2
  • La edad media de presentación es 12.3 ± 3.5 años (rango 5.7-17.8 años) 2

En Población Adulta

  • Los corticotropinomas representan solo el 4% de todos los adenomas hipofisarios en adultos 1
  • Entre 8.8% y 21% de los adenomas hipofisarios tratados quirúrgicamente en población pediátrica están asociados con exceso de hormona de crecimiento, no con Cushing 2

Contexto Clínico Importante

Proporción dentro del Síndrome de Cushing

Es crucial distinguir entre:

  • La enfermedad de Cushing (adenoma hipofisario secretor de ACTH) representa el 75-80% de todos los casos de síndrome de Cushing en niños y adolescentes 2
  • En adultos, la enfermedad de Cushing representa entre 49-71% de los casos de síndrome de Cushing 2
  • Aproximadamente el 70% de todos los pacientes con síndrome de Cushing endógeno tienen enfermedad de Cushing (origen hipofisario) 3, 4

Distribución de Tipos de Adenomas Hipofisarios

Para contextualizar la proporción de corticotropinomas:

  • Los prolactinomas son el tipo más común, representando aproximadamente el 53% de todos los adenomas hipofisarios 1
  • Los somatotropinomas (secretores de hormona de crecimiento) representan el 12% 1
  • Los corticotropinomas representan el 4% 1
  • Los adenomas no funcionantes representan el 30% 1

Características Específicas de los Corticotropinomas

Tamaño Tumoral

  • Los microadenomas (≤2 mm frecuentemente) representan el 98% de los casos de enfermedad de Cushing en población pediátrica 2
  • Los macroadenomas son raros en niños (2-5% versus 10% en adultos) 2

Diferencias por Sexo

  • En población pediátrica existe predominio masculino (63% niños), especialmente en edad prepuberal (71% niños) 2
  • En adultos, el 79% de los pacientes con enfermedad de Cushing son mujeres 2

Implicaciones Clínicas

La baja prevalencia de corticotropinomas (4%) entre todos los adenomas hipofisarios en adultos contrasta marcadamente con su alta prevalencia (55%) en niños pequeños, lo que tiene implicaciones importantes para el índice de sospecha clínica según la edad del paciente. 2, 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Cushing's disease.

Handbook of clinical neurology, 2014

Research

Evaluation and treatment of Cushing's syndrome.

The American journal of medicine, 2005

Related Questions

What is the priority surgical procedure for an elderly female patient with a hernia and an adrenal gland disorder, such as Cushing's syndrome or an adrenal tumor, requiring both hernia repair and adrenal gland removal?
What is the recommended diagnostic workup and treatment for a 33-year-old patient with suspected pituitary tumor, irregular periods, dizziness, vomiting, and previous elevated prolactin levels?
What is the best course of treatment for a 30-year-old female with a history of pituitary microadenoma, hyperprolactinemia (elevated prolactin levels), hyperandrogenism (elevated testosterone levels), and leukocytosis (elevated white blood cell count), who has been taking Oviastil (clomiphene citrate) for 6 months with no improvement in symptoms, including oligomenorrhea (missed periods)?
What is the approach to diagnosing and treating Cushing's syndrome?
What is the best next step in evaluating a patient with a pituitary macroadenoma and no reported sleep-related issues before undergoing hypophysectomy?
What is the diagnosis for vomiting in an adult patient with type 2 diabetes or obesity after taking Ozempic (semaglutide)?
Can existing medications be continued after surgery?
What is the appropriate management for a patient with hyperglycemia, impaired renal function, hypokalemia, cardiac stress or injury, anemia, and malnutrition or liver dysfunction?
What is the role of Nuhu's classification in guiding treatment decisions for a child with hypospadias?
What is the recommended treatment approach for a patient presenting with alcohol intoxication, considering potential complications and pre-existing medical conditions?
What is the best current treatment for varicose veins?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.